Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study

Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study

BackgroundTreatment of locally advanced unresectable non-small cell lung cancer (NSCLC) is a significant challenge, especially for patients with IIIA/IIIB NSCLC. Patients receiving neoadjuvant chemoimmunotherapy (NCI) show improved pathological responses and disease-free survival (DFS) compared to t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuchen Wang, Xiaobo Ma, Kewei Ma, Xi Chen, Hua He, Xiangye Zhao, Mengge Fan, Yinghui Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
non-small cell lung cancer
neoadjuvant therapy
chemoimmunotherapy
potentially resectable
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1479263/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1479263/full

Similar Items